What is Hormona?
Launched in 2020 by Karolina Löfqvist and Jasmine Tagesson, Hormona is a specialized healthtech enterprise dedicated to the development of sophisticated digital tools and hardware. The company addresses a significant gap in the market by enabling women to monitor, interpret, and manage hormonal fluctuations with clinical precision. By integrating proprietary diagnostic technology with user-centric digital interfaces, Hormona empowers users to gain actionable insights into their physiological health, effectively bridging the divide between traditional medical diagnostics and consumer-facing wellness applications.
How much funding has Hormona raised?
Hormona has raised a total of $6.8M across 2 funding rounds:
Seed
$6.7M
Grant
$136K
Seed (2025): $6.7M with participation from DLF Venture, Nascent Investments, Techstars, Supernode Global, and Voima Ventures
Grant (2025): $136K led by UK Research & Innovation
Key Investors in Hormona
DLF Venture
A family-owned investment firm that provides strategic support to consumer-oriented brands, focusing on long-term growth and detail-oriented partnerships in the health and care sectors.
Techstars
A global accelerator and venture capital firm that fosters innovation by connecting startups with a vast network of mentors, investors, and corporate partners.
Supernode Global
An early-stage venture capital fund specializing in consumer and B2B technologies that enhance personal wellbeing and productivity through a conviction-driven investment approach.
What's next for Hormona?
With the recent influx of capital, Hormona is poised to transition from its initial development phase into a period of aggressive market scaling and technological refinement. The company's roadmap likely includes the expansion of its diagnostic hardware capabilities and the enhancement of its data analytics platform to provide more personalized health recommendations. Furthermore, the involvement of diverse investors—ranging from deep-tech focused venture firms to public research bodies—suggests a multi-faceted growth strategy that prioritizes both scientific rigor and commercial viability. As Hormona continues to navigate the complexities of the healthtech industry, its focus will remain on establishing a robust, evidence-based framework for hormonal health management on a global scale.
See full Hormona company page
